-
Article
Open AccessHe Pikinga Waiora: supporting Māori health organisations to respond to pre-diabetes
Type 2 Diabetes (T2D) is a common long-term condition affecting the health and wellbeing of New Zealanders; one in every four New Zealanders is pre-diabetic. Māori, the Indigenous people of New Zealand, are at...
-
Article
Open AccessImplementation framework for chronic disease intervention effectiveness in Māori and other indigenous communities
About 40% of all health burden in New Zealand is due to cancer, cardiovascular disease, and type 2 diabetes/obesity. Outcomes for Māori (indigenous people) are significantly worse than non-Maori; these inequit...
-
Article
Suppression of β-casein gene expression by inhibition of protein synthesis in mouse mammary epithelial cells is associated with stimulation of NF-κB activity and blockage of prolactin-Stat5 signaling
The protein synthesis inhibitor cycloheximide (Chx) suppresses prolactin-induced β-casein gene expression in the mammary epithelial cell line COMMA-D. As the mechanism underlying this effect is unclear, the ef...
